Clear cell sarcoma research hub

A study to explore the effect of immunotherapy drug, tebentafusp, on patients with clear cell sarcoma (ultra-rare, aggressive type of soft tissue sarcoma that primarily affects young adults)

This study looks at a medicine called tebentafusp for a rare cancer called clear cell sarcoma. Researchers want to see if the drug works and how long its effects last. It's for adults with advanced clear cell sarcoma.